Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung
Scientists develop a formulation for the pulmonary administration of siRNA. The aim was to suppress the replication of SARS-CoV-2.
Stay updated with breaking news from Cell Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists develop a formulation for the pulmonary administration of siRNA. The aim was to suppress the replication of SARS-CoV-2.
Researchers demonstrated that E proteins of β-coronaviruses could restrict HIV-1 infection.
Researchers assessed the roles of the interferon regulatory factors: IRF1, IRF3, and IRF7 in infections by human coronaviruses.
ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHOTM Transient Expression System.
To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus: polymerase.